Alle Publikationen

Filtern Sie das Suchergebnis:

Alle Vortrag Poster Abstract Fullpaper

Ihr Suchergebnis:

(1) Musholt PG., Schöndorf T., Pfützner A., Hohbert C., Kleine I., Fuchs W., Hehenwarter S., Dikta G., Kerschgens B., Forst T.
Combined Pioglitazone and Metformin Treatment Maintains the Beneficial Effect of Short-Term Insulin Infusion in Patients with Type 2 Diabetes
Results from a Pilot Study. J of Diab Science and Technology. Vol 3, Vol 3, Iss 6 (Nov. 2009)
(Fullpaper)

(2) Forst T., Hohberg C., Tarakci E., Forst S., Kann P., Pfützner A.
Reliability of Lightguide Spectrophotometry (O2CR) for the Investigation of Skin Tissue Microvascular Blood Flow and Tissue Oxygen Supply in Diabetic and Nondaibetic Subjects.
J of Diab Science and Technology. Vol 2, 151-155 (Nov. 2008)
(Fullpaper)

(3) Schöndorf T., Karagiannis E., Posseldt RE., Forst T., Pfützner A.
Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type diabetes patients with insufficient glycemic control by metformin alone – results from a post-marketing surveillance trial under daily routine conditions.
Diabetes Technol Ther., 11(6):379-83 (Jun 2009)
(Fullpaper)

(4) Forst T., Hohbert C., Schöndorf T., Borchert M., Forst S., Roth W., Dehos B. Pfützner A.
Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the Plex Pen device.
Diabetes Technol Ther, 11(2): 87-92 (Feb. 2009)
(Fullpaper)

(5) Foucher AL, Hartmann K., Hauptmann M., Wildgrunber R., Safinowski M., Forst T., Pfützner A., Gelfand CA., Nissum M.
Resolution of adiponenctin oligomers in human plasma using free flow electrophoresis.
Arch Physiol Biochem, 115(5):267-8 (Dez. 2009)
(Fullpaper)

(6) Pfützner A., Prause S., Eidens M., Weise A., Forst T.
Pharmgenomics of Metabolic Disease.
Gent The EuroEspes Journal, No. 4, S. 9-16 (Dez. 2009)
(Fullpaper)

(7) Dahmen N., Manderscheid N., Helfrich J., Musholt PB, Forst T, Pfützner A., Engel A.
levated peripheral visfatin levels in narcoleptic patients.
PloS One, 3(8):e2980 (Aug. 2008)
(Fullpaper)

(8) Pfützner A., Harzer O., Mushol PB., Scherer S., Löbig M., Forst T.
Performance of Blood Glucose Measurement Systems Influenced by Interfering Substances.
Diabetes, Stoffwechsel und Herz, Band 18 (5/2009)
(Fullpaper)

(9) Pfützner A., Safinowski M., Forst T.
Problems with the determination of nitrotyrosine in human plasma are not solved in a satisfactory way and conclusions from clinical trials need to be carefully revised.
Clin Chem Labo Med 2010, 48 (1): 145-146 (2010)
(Fullpaper)

(10) Forst T., Pfutzner A., Flacke F., Krasner A., Hohberg C., Tarakci E., Pichotta P. Forst S., Steiner S.
Postprandial Vascular Effects of VIAject Compared With Insulin Lispro and Regular Human Insulin in Patients With Type 2 Diabetes.
Diabetes Care, Col 33, Number 1 (2010)
(Fullpaper)